多发性硬化症的诊断、预后和疾病监测生物标志物的最新进展

IF 2.4 4区 医学 Q2 CLINICAL NEUROLOGY Neurologic Clinics Pub Date : 2023-08-05 DOI:10.1016/j.ncl.2023.06.008
Anibal Chertcoff MD , Raphael Schneider MD, PhD , Christina J. Azevedo MD, MPH , Nancy Sicotte MD , Jiwon Oh MD, PhD
{"title":"多发性硬化症的诊断、预后和疾病监测生物标志物的最新进展","authors":"Anibal Chertcoff MD , Raphael Schneider MD, PhD , Christina J. Azevedo MD, MPH , Nancy Sicotte MD , Jiwon Oh MD, PhD","doi":"10.1016/j.ncl.2023.06.008","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":49759,"journal":{"name":"Neurologic Clinics","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2023-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis\",\"authors\":\"Anibal Chertcoff MD , Raphael Schneider MD, PhD , Christina J. Azevedo MD, MPH , Nancy Sicotte MD , Jiwon Oh MD, PhD\",\"doi\":\"10.1016/j.ncl.2023.06.008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":49759,\"journal\":{\"name\":\"Neurologic Clinics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2023-08-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurologic Clinics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0733861923000622\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurologic Clinics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0733861923000622","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

多发性硬化症(MS)是一种高度异质性的疾病。目前,临床实践将临床特征、MRI和脑脊液标志物结合起来用于诊断和治疗决策。近年来,人们一直在努力开发新的生物标志物,以更好地反映疾病的病理基础,以帮助诊断和早期预后,评估持续的炎症活动,检测和监测疾病进展,预测治疗反应,以及监测疾病改善治疗的安全性。在这篇综述中,作者概述了在多发性硬化症的诊断、预后和疾病监测/治疗反应生物标志物方面有希望的最新进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Neurologic Clinics
Neurologic Clinics 医学-临床神经学
CiteScore
5.00
自引率
4.20%
发文量
92
审稿时长
6-12 weeks
期刊介绍: Targeted toward those in the fields of neurology, family medicine, otolaryngology, and pediatrics, Neurologic Clinics offers a broad view of current practice, as well as the evidence to support it. Published quarterly — in February, May, August, and November — each issue focuses on a single topic neurology, including hearing loss, cholesteatoma, rhinology, anosmia, dysphagia, and pediatric-specific ENT.
期刊最新文献
Contents Advances in the Critical Care of Ischemic Brain Infarction The Explosive and Exciting Growth of Neurocritical Care Neurocritical Care Copyright
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1